Source The Institute of Cancer Research: "Scientists unveil prostate cancer’s ‘Rosetta Stone’. Almost 90% of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs, a landmark new study reveals...."
... The research is published today in the major scientific journal Cell, and is funded by Stand up to Cancer and the Prostate Cancer Foundation...
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_1VWhdbAxbLc4JF7jr9ABrJEQx4jzx5Zpo-_pupao_FJtQtCQQOlpQdV5uzp7FBWsj6KAJNxZB2ckSVXw2epRMcRq7Lj-6XoHWNAYe4fqWMizgyHQEA3L2zhDGH60PoDwgEs35ByGcds/s320/ICR+Logo.png)
... Professor Paul Workman, Chief Executive and President of the ICR, said: “Cancer becomes lethal at the stage when it spreads round the body and stops responding to treatment – but until now it has been incredibly difficult to find out exactly what is going on genetically at that critical point... "
Unveiling prostate cancer’s ‘Rosetta Stone’ from The Institute of Cancer Research on Vimeo.